We provide you with 20 years of free, institutional-grade data for MRKR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRKR. Explore the full financial landscape of MRKR stock.
| Reported Date | CIK | Ticker | Type |
|---|
Marker Therapeutics, Inc(NASDAQ:MRKR) 
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technolog...
Website: http://www.markertherapeutics.com
Founded: 1992
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MRKR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.